Prelude Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $59k | 29k | 2.07 |
| 2024-06-30 | $138k | 36k | 3.81 |
| 2024-03-31 | $190k | 40k | 4.74 |
| 2023-12-31 | $216k | 51k | 4.27 |
| 2023-09-30 | $102k | 33k | 3.09 |
| 2023-06-30 | $139k | 31k | 4.50 |
| 2022-12-31 | $174k | 29k | 6.04 |
| 2022-09-30 | $245k | 29k | 8.40 |
| 2022-06-30 | $153k | 29k | 5.23 |
| 2022-03-31 | $409k | 60k | 6.84 |
| 2021-12-31 | $485k | 58k | 8.40 |
| 2021-09-30 | $1.1M | 34k | 31.20 |
| 2021-06-30 | $866k | 30k | 28.61 |
| 2021-03-31 | $1.3M | 31k | 43.35 |
| 2020-12-31 | $2.2M | 31k | 71.48 |